Disease / condition

Urothelial Carcinoma clinical trials

Free access to 113 studies·10+ countries·Updated daily37 recruiting
113
Total trials
10+
Countries
10+
Sponsors
37
Recruiting
By phase
Phase 245
N/A36
Phase 111
Phase 1/26
Early Phase 16
By status
Recruiting37
Not yet recruit...23
Completed17
Active, not rec...12
Unknown9
Top countries
United States of America34
China21
Taiwan7
France5
South Korea4
Top sponsors
National Taiwan Un...4
University of Mich...4
Seagen Inc.3
The Netherlands Ca...3
Memorial Sloan Ket...3
Recent trials
Latest clinical trials for Urothelial Carcinoma
NCT06405425·Phase 2Not yet recr...
A Study of BL-B01D1 + PD-1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
Sichuan Baili Pharmaceutical C...China
NCT06421311Not yet recr...
Observational Study of Muscle Invasive Urothelial Carcinoma Participants Treated With Adjuvant Nivolumab in France
Bristol-Myers SquibbFrance
NCT06412848Recruiting
JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study
Merck Healthcare KGaA, Darmsta...Japan
NCT06356155·Phase 2Not yet recr...
Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Cisplatin-eligible Upper Tract Urothelial Cancer
University of Michigan Rogel C...United States of America
NCT06262516Not yet recr...
Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma
Case Comprehensive Cancer Cent...United States of America
NCT06310759Recruiting
Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer
Tampere University HospitalCanada,Finland
NCT06120413Recruiting
18F-LN1 PET/CT in Urothelial Carcinomas
Sichuan Provincial People's Ho...China
NCT06120374Recruiting
Adjuvant Radiotherapy and Combined Adjuvant Treatment Strategy for UTUC
Peking University First Hospit...China
NCT06116396Recruiting
Liquid Biospy for Urinary Cancers
IRCCS San RaffaeleItaly
NCT06113367Not yet recr...
Immunotherapy in Upper Tract Urothelial Carcinoma
Assistance Publique - Hôpitaux...
NCT05965856·Phase 2Not yet recr...
A Study of BL-B01D1+SI-B003 in the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors
Sichuan Baili Pharmaceutical C...China
NCT05912205·Phase 2Not yet recr...
Disitamab Vedotin Combined With Radiotherapy for Bladder Preservation
Wuhan Union Hospital, China
NCT05911295·Phase 3Recruiting
Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2
Seagen Inc.United States of America
NCT05902494Recruiting
HER2 and LA/mUC: A Multi-country Chart Review Cohort Study
Seagen Inc.United States of America
NCT05894447·Phase 1Not yet recr...
Naptumomab Estafenatox in Combination With Pembrolizumab Preceded by Obinutuzumab in Patients With Urothelial Cancers
Weill Medical College of Corne...United States of America
NCT05889195Not yet recr...
Detection and Risk Stratification in Veterans Presenting With Microscopic Hematuria
Pacific Edge LimitedUnited States of America
NCT05868265·Phase 2Recruiting
A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract
Memorial Sloan Kettering Cance...United States of America
NCT05600127·Phase 2Not yet recr...
Chemotherapy and Sequential Immunotherapy for Locally Advanced Urothelial Cancer
Erasmus Medical Center
NCT05775874·Phase 2Recruiting
A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC
Abbisko Therapeutics Co, LtdChina
NCT05562830·Phase 1/2Recruiting
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
Merck Sharp & Dohme LLCAustralia,Israel,South Korea,Spain
About this record

Access comprehensive clinical trial information for Urothelial Carcinoma through Pure Global AI's free database. This collection includes 113 clinical trials across multiple phases including Phase 2, N/A, Phase 1. Currently, 37 trials are actively recruiting participants.

Research for Urothelial Carcinoma is being conducted in United States of America, China, Taiwan and 7+ other countries. Leading sponsors include National Taiwan University Hospital and University of Michigan Rogel Cancer Center. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 113 clinical trials studying Urothelial Carcinoma, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include National Taiwan University Hospital, University of Michigan Rogel Cancer Center, Seagen Inc., among others.